What Market Size Is Projected For The Heart Defect Closure Device Market By 2030?
The heart defect closure device market size has grown rapidly in recent years. It will grow from $1.27 billion in 2025 to $1.45 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, advancements in interventional cardiology, growing awareness of septal defect treatments, expansion of cardiac catheterization labs, rising demand for minimally invasive cardiac procedure.
The heart defect closure device market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growing elderly and pediatric patient population with structural heart defects, rising adoption of transcatheter cardiac interventions, increasing healthcare expenditure on cardiovascular care, expansion of specialized cardiac centers, growing focus on early diagnosis and treatment of heart defects. Major trends in the forecast period include rising adoption of minimally invasive transcatheter closure procedures, growing use of nitinol-based and self-expanding closure devices, increasing preference for device-based alternatives to open-heart surgery, expansion of structural heart disease treatment programs, rising focus on improved safety, efficacy, and long-term outcomes.
Claim Your Free Report Sample Today:
Which Primary Market Drivers Are Fueling Momentum In The Heart Defect Closure Device Market?
The growing number of people with congenital heart problems is expected to propel the growth of the heart defect closure device market going forward. Congenital heart problems refer to structural defects in the heart that are present at birth. The increase in congenital heart problems is due to genetic predispositions, environmental influences, and maternal health issues such as diabetes, obesity, and exposure to certain medications or infections during pregnancy. Heart defect closure devices help to treat congenital heart problems by offering minimally invasive solutions to seal abnormal heart openings, thus restoring normal blood flow, reducing complications, and improving overall cardiac function. For instance, in August 2025, according to the National Center for Biotechnology Information, a US-based governmental agency, between 2025 and 2050, cardiovascular disease is projected to rise significantly, with prevalence increasing by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, leading to an estimated 35.6 million cardiovascular deaths in 2050, up from 20.5 million in 2025. Therefore, the growing number of people with congenital heart problems is driving the heart defect closure device market.
What Major Market Segments Contribute To Shaping The Overall Framework Of The Heart Defect Closure Device Market?
The heart defect closure device market covered in this report is segmented –
1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices
2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders
4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders
5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders
What Current Industry Trends Are Affecting The Performance Of The Heart Defect Closure Device Market?
Major companies in the heart defect closure device market are advancing technologies such as device tracking tools to enhance procedural precision and clinician confidence. A device tracking tool is a system that provides real-time visualization of the position and movement of medical devices during treatment. For instance, in November 2025, Philips, a Netherlands-based health technology company, introduced DeviceGuide—an AI-driven tracking solution designed to support clinicians during complex minimally invasive heart valve repair procedures, especially for mitral valve regurgitation. Integrated with the EchoNavigator platform, DeviceGuide merges live X-ray and ultrasound imaging to generate a real-time 3D model of the repair device within the beating heart, improving visualization, orientation, and accuracy. Developed in collaboration with Edwards Lifesciences, the system streamlines workflows, enhances team coordination, and supports broader access to advanced cardiac interventions worldwide.
Who Are The Established And Emerging Players Expanding Their Footprint In The Heart Defect Closure Device Market?
Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, W L Gore and Associates, Occlutech, LifeTech Scientific Corporation, Lepu Medical Technology, Meril Life Sciences Pvt Ltd, MicroPort Scientific Corporation, Boston Scientific Corporation, Edwards Lifesciences, Terumo Corporation, Cardia Inc, Coherex Medical Inc, AtriCure Inc, Sahajanand Medical Technologies Limited, Vivasure Medical, Transmural Systems Inc, Cormatrix Cardiovascular Inc, Baylis Medical Company Inc, Biosense Webster Inc, BIOTRONIK SE and Co KG, B Braun
Get Your In-Depth Heart Defect Closure Device Market Report Now:
Which Regional Clusters Are Forecasted To Outperform Others In The Heart Defect Closure Device Market?
North America was the largest region in the heart defect closure device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment